Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605Peter C. Black, Seth P. Lerner, M. Scott Lucia et al.|European Urology|2023Cited by 96
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder CancerAndrea B. Apolo, Sundeep Agrawal, Matthew I. Milowsky et al.|JAMA Oncology|2019Cited by 9